356 related articles for article (PubMed ID: 8772697)
1. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts.
Zaugg CE; Hornstein PS; Zhu P; Simper D; Lüscher TF; Allegrini PR; Buser PT
Circulation; 1996 Aug; 94(4):742-7. PubMed ID: 8772697
[TBL] [Abstract][Full Text] [Related]
2. Combined blockade of endothelin-1 and thromboxane A(2) receptors against postischaemic contractile dysfunction in rat hearts.
Hornstein PS; Zaugg CE; Zhu P; Allegrini PR; Buser PT
Br J Pharmacol; 2001 Jan; 132(1):234-40. PubMed ID: 11156582
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of endothelin-1 on normal and postischemic reperfused myocardium.
Zaugg CE; Zhu P; Simper D; Lüscher TF; Allegrini PR; Buser PT
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S367-70. PubMed ID: 7509989
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: involvement of isoprostanes.
Möbert J; Becker BF
J Am Coll Cardiol; 1998 Jun; 31(7):1687-94. PubMed ID: 9626852
[TBL] [Abstract][Full Text] [Related]
5. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition.
Pomposiello S; Yang XP; Liu YH; Surakanti M; Rhaleb NE; Sevilla M; Carretero OA
J Cardiovasc Pharmacol; 1997 Nov; 30(5):599-606. PubMed ID: 9388042
[TBL] [Abstract][Full Text] [Related]
6. Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury?
Byrne JG; Appleyard RF; Sun SC; Couper GS; Sloane JA; Laurence RG; Cohn LH
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):689-93. PubMed ID: 8469003
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of dimethyl amiloride against postischemic myocardial dysfunction in rabbit hearts: phosphorus 31-nuclear magnetic resonance measurements of intracellular pH and cellular energy.
Koike A; Akita T; Hotta Y; Takeya K; Kodama I; Murase M; Abe T; Toyama J
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):765-75. PubMed ID: 8800166
[TBL] [Abstract][Full Text] [Related]
8. Effect of thromboxane A2 synthetase inhibitor on metabolism and contractility in ischemic reperfused rabbit heart.
Kawabata H; Ryomoto T; Katori R
Angiology; 1997 Aug; 48(8):689-97. PubMed ID: 9269138
[TBL] [Abstract][Full Text] [Related]
9. Direct myocardial effects of the thromboxane A2/prostaglandin H2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditions.
Grover GJ; Hedberg A; Ogletree ML
Pharmacology; 1990; 41(1):1-15. PubMed ID: 2122481
[TBL] [Abstract][Full Text] [Related]
10. Activation of TxA2/PGH2 receptors and protein kinase C contribute to coronary dysfunction in superoxide treated rat hearts.
Gupte SA; Okada T; Tateyama M; Ochi R
J Mol Cell Cardiol; 2000 Jun; 32(6):937-46. PubMed ID: 10888248
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats.
Xu H; Korneszczuk K; Karaa A; Lin T; Clemens MG; Zhang JX
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G277-83. PubMed ID: 15647606
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation.
Sibelius U; Grandel U; Buerke M; Mueller D; Kiss L; Kraemer HJ; Braun-Dullaeus R; Haberbosch W; Seeger W; Grimminger F
Circulation; 2000 Jan 4-11; 101(1):78-85. PubMed ID: 10618308
[TBL] [Abstract][Full Text] [Related]
13. Effect of an endothelin receptor antagonist and an angiotensin converting enzyme inhibitor on metabolism and contraction in the ischemic and reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 1999 Oct; 63(10):770-4. PubMed ID: 10553919
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
[TBL] [Abstract][Full Text] [Related]
15. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
16. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.
de Groot MC; Illing B; Horn M; Urban B; Haase A; Schnackerz K; Neubauer S
J Mol Cell Cardiol; 1998 Dec; 30(12):2657-68. PubMed ID: 9990537
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of protection afforded by cyclooxygenase inhibitors to endothelial function against ischemic injury in rat isolated hearts.
Bouchard JF; Lamontagne D
J Cardiovasc Pharmacol; 1999 Nov; 34(5):755-63. PubMed ID: 10547094
[TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels.
Howarth SR; Vallance P; Wilson CA
Placenta; 1995 Dec; 16(8):679-89. PubMed ID: 8710799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
